header logo
Vallibel FD
vallible LE
Latest
Cuba approves emergency use of home-grown COVID vaccine
Cuba approves emergency use of home-grown COVID vaccine
Mobitel inner 1278

Cuba on Friday approved its home-grown Abdala vaccine for emergency use, the first Latin American coronavirus jab to reach this stage and a possible lifeline for a region trying to battle a killer pandemic with modest means.

 

The country’s CECMED health regulator gave the go-ahead after Abdala’s makers last month announced the vaccine candidate was more than 92 percent effective at preventing COVID-19 disease after three doses.

 

Cuba is working on five coronavirus vaccines, and in May started immunizing its population using two of them -- Abdala and Soberana 2 -- even before they received approval.

 

By this week, 6.8 million of Cuba’s 11.2 million people have received at least one dose of either vaccine, while 1.6 million have the required three doses.

 

The country has not bought or sought vaccines from elsewhere, and aims to immunize its population before the end of the year.

 

In June, the state-run BioCubaFarma laboratory said Abdala “shows efficacy of 92.28 percent in its three-dose scheme.”

 

The World Health Organization has set a 50-percent efficacy threshold for coronavirus vaccines to qualify for approved global roll-out, though individual countries can green-light jabs without the UN stamp for domestic use.

 

The CECMED said approval of Abdala was based on its analysis that it met requirements for “quality, safety and effectiveness.”

 

And Aica Laboratories, where the vaccine is produced, said there had been “a rigorous process of evaluation of the dossier and... inspections of the plants involved.”

 

Under American sanctions, communist Cuba has a long tradition of making its own vaccines, dating back to the 1980s.

 

Nearly 80 percent of its inoculations are produced locally.

 


Soberana 2 next?

 

On Thursday, the Finlay Institute which makes Soberana 2 said it, too, showed efficacy exceeding 91 percent after three doses.

 

Eduardo Martinez, president of BioCubaFarma, said Soberana 2 will be submitted to the regulatory authority in the coming days for its own emergency approval.

 

Cuba has recorded more than 224,000 COVID-19 cases among its population of 11.2 million, and some 1,450 deaths.

 

It has seen a recent spike in infections, with a new daily infection record reported Friday.

 

On Wednesday, authorities sent an urgent deployment of doctors and medical equipment to the province of Matanzas -- where foreign tourists have continued to visit -- after hospitals there reached capacity.

 

A local company has been commissioned to make more hospital beds for Matanzas and there is a social media campaign to raise donations.

 

Elsewhere in Latin America, the situation remains worrying.

 

Brazil has the world’s second-highest death toll -- more than 530,000. Colombia recently crossed the grim threshold of 100,000 coronavirus deaths and Peru is now the country with the world’s highest death toll per capita.

 

Mexico, whose recorded death toll of 234,000 is the fourth-highest in the world, said Tuesday it is battling a fresh pandemic wave.

 

A locally produced vaccine offers a glimpse of hope for Latin America and the Caribbean, a region which the UN says has fully vaccinated just over 13.6 percent of its population compared to 34.9 percent in the European Union and 46.3 percent in North America.

 

The region comprises a third of the world’s coronavirus death toll despite representing just 8.4 percent of the global population.

 

Venezuela has signed a contract to purchase 12 million doses of Abdala and has already started using the Cuban jab in its vaccination campaign.

 

Argentina’s health minister visited the island in May to discuss a possible vaccine deal and Mexico has expressed interest.

 

There is no requirement for the WHO to approve such bilateral vaccine deals.

 

Abdala and Soberana 2 are recombinant protein vaccines that work by recreating the “spikes” on the surface of the coronavirus and introducing it to the body, training the immune system to recognize intruders and fight back in case of a real infection.

 

Recombinant vaccines, unlike some coronavirus shots already in use, do not need extreme refrigeration.

 

Source: AFP
-Agencies

 

 

 

Disclaimer: All the comments will be moderated by the AD editorial. Abstain from posting comments that are obscene, defamatory or slanderous. Please avoid outside hyperlinks inside the comment and avoid typing all capitalized comments. Help us delete comments that do not follow these guidelines by flagging them (mouse over a comment and click the flag icon on the right side). Do use these forums to voice your opinions and create healthy discourse.

Comments

0
Comments are disabled

Note: Due to legal constraints, the Ada Derana Editorial team has taken a decision to disable comments on all articles concerning ongoing court procedures.

MostRead
Mobitel 1278
VideoStories
 Anuradhapura Sacred City Development Plan; Acting Atamasthanadhipathi calls for public cooperation

Anuradhapura Sacred City Development Plan; Acting Atamasthanadhipathi calls for public cooperation

 Namal produced in court over ‘Krrish’ transaction case; CID findings to court in Jan. 2027

Namal produced in court over ‘Krrish’ transaction case; CID findings to court in Jan. 2027

CAA issues notice to LAUGFS Gas;Supply gas or refund customers who purchased cylinders, company told

CAA issues notice to LAUGFS Gas;Supply gas or refund customers who purchased cylinders, company told

Sajith calls for stronger Sri Lanka-China ties;  Focus on innovation and sustainable economic growth

Sajith calls for stronger Sri Lanka-China ties; Focus on innovation and sustainable economic growth

"Turn budget promises into reality" Sajith says development projects must deliver tangible benefits

"Turn budget promises into reality" Sajith says development projects must deliver tangible benefits

“SL has reached a macro-stabilisation milestone” Govt. defends its investment and procurement policy

“SL has reached a macro-stabilisation milestone” Govt. defends its investment and procurement policy

Another bankruptcy risk?  Opposition questions feasibility of Rs. 2 trillion capital spending target

Another bankruptcy risk? Opposition questions feasibility of Rs. 2 trillion capital spending target

Global Lankan Entrepreneur Club launched;  Dilith Jayaweera unveils global business platform

Global Lankan Entrepreneur Club launched; Dilith Jayaweera unveils global business platform

Heavy rains expected in Northern and Eastern areas  - Met Department warns

Heavy rains expected in Northern and Eastern areas - Met Department warns

Van driver arrested after collision with motorcycle  kills father and son in Chavakachcheri

Van driver arrested after collision with motorcycle kills father and son in Chavakachcheri

Laugfs Gas CEO apologises to consumers  over LP gas shortage, explains price hike

Laugfs Gas CEO apologises to consumers over LP gas shortage, explains price hike

Policy inconsistencies hinder investor confidence   - Tax specialist says at post-budget forum

Policy inconsistencies hinder investor confidence - Tax specialist says at post-budget forum

SEC backs key 2027 Budget proposals  to strengthen capital market

SEC backs key 2027 Budget proposals to strengthen capital market

‘AI Center of Excellence’ aims to develop industry-specific solutions-Dy Minister of Digital Economy

‘AI Center of Excellence’ aims to develop industry-specific solutions-Dy Minister of Digital Economy

JVP marks 37th November Heroes’ Day  under President’s patronage today

JVP marks 37th November Heroes’ Day under President’s patronage today

Lassana Flora